We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 27, 2020

Nelarabine Effective in Newly Diagnosed T-Cell ALL

Journal of Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
J. Clin. Oncol 2020 Aug 19;[EPub Ahead of Print], KP Dunsmore, SS Winter, M Devidas, BL Wood, N Esiashvili, Z Chen, N Eisenberg, N Briegel, RJ Hayashi, JM Gastier-Foster, AJ Carroll, NA Heerema, BL Asselin, KR Rabin, PA Zweidler-Mckay, EA Raetz, ML Loh, KR Schultz, NJ Winick, WL Carroll, SP Hunger

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading